A Phase 2/3 Adaptive Double-blind Placebo-Controlled Study to Evaluate the Efficacy and Safety of VX-147 in Subjects Adult and Pediatric subjects With APOL1-mediated Proteinuric Kidney Disease

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions:
    Apol1-mediated Proteinuric Kidney Disease
  • Age: Between 18 Year(s) - 60 Year(s)
  • Gender: Male or Female
  • Other Inclusion Criteria:
    1. Diagnosed with chronic kidney disease.

You may not be eligible for this study if the following are true:

    1. Participant has diabetes.
    2. Ongoing participation in a clinical study (except Vertex genotyping VX19-NEN-801 study).



If you are registered as a volunteer, please log in to contact the study team/express interest in this study.